News

CMN Weekly (15 October 2021)

Some of the best links we picked up around the internet

By: Gorm Palmgren - Oct. 15, 2021

Top picks

Research

Industry

Clinical News

COVID-19

Reviews

Opinion

  • Future Medicine brings an interview with Geoff MacKay, who talks about new gene therapies for rare diseases. MacKay is the CEO of AVROBIO, a clinical-stage lentiviral gene therapy company that treats lysosomal disorders, and a board member of Talaris Therapeutics and Satellos Bioscience.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN WeeklyHashtagAllogene Therapeutics, Inc.HashtagCRISPR Therapeutics AGHashtagIntellia Therapeutics, Inc.HashtagPoseida TherapeuticsHashtagPrecision BioSciences, Inc.HashtagSarepta Therapeutics

News: CMN Weekly (15 October 2021)
CLINICAL TRIALS
Sickle Cell Disease, SCD
Sponsors:
Beam Therapeutics
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Hereditary Angioedema, HAE (NCT05120830)
Sponsors:
Intellia Therapeutics
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Acute Myeloid Leukemia, AML, (NCT05066165)
Sponsors:
Intellia Therapeutics
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine